Structural basis for norovirus inhibition by human milk oligosaccharides

Journal of Virology

Volumn 90, Issue 9, 2016, Pages 4843-4848

  Weichert, Stefan ^a   Koromyslova, Anna ^b   Singh, Bishal K ^b   Hansman, Satoko ^a,b   Jennewein, Stefan ^c   Schroten, Horst ^a   Hansman, Grant S ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Jennewein Biotechnologie GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2' FUCOSYLLACTOSE; 3 FUCOSYLLACTOSE; BLOOD GROUP ANTIGEN; HISTO BLOOD GROUP ANTIGEN; OLIGOSACCHARIDE; PORCINE GASTRIC MUCIN TYPE III; STOMACH MUCIN; UNCLASSIFIED DRUG; 2'-FUCOSYLLACTOSE; 3'-FUCOSYLLACTOSE; ANTIVIRUS AGENT; PROTEIN BINDING; TRISACCHARIDE;

ANTIGEN BINDING; ARTICLE; BINDING SITE; BREAST MILK; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IC50; NONHUMAN; NOROVIRUS; NOROVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; SALIVA ANALYSIS; VIRUS ATTACHMENT; VIRUS CAPSID; VIRUS INHIBITION; VIRUS LIKE AGENT; VIRUS MORPHOLOGY; VIRUS PURIFICATION; X RAY CRYSTALLOGRAPHY; CHEMISTRY; CONFORMATION; DRUG EFFECTS; METABOLISM; MOLECULAR MODEL; STRUCTURE ACTIVITY RELATION;

ANTIVIRAL AGENTS; BLOOD GROUP ANTIGENS; CRYSTALLOGRAPHY, X-RAY; HUMANS; MILK, HUMAN; MODELS, MOLECULAR; MOLECULAR CONFORMATION; NOROVIRUS; OLIGOSACCHARIDES; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; STRUCTURE-ACTIVITY RELATIONSHIP; TRISACCHARIDES;

EID: 84964959937     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03223-15     Document Type: Article

References (27)

1. Kunz C, Rudloff S, Baier W, Klein N, Strobel S. 2000. Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annu Rev Nutr 20:699-722. http://dx.doi.org/10.1146/annurev.nutr.20.1.699.
2. Etzold S, Bode L. 2014. Glycan-dependent viral infection in infants and the role of human milk oligosaccharides. Curr Opin Virol 7:101-107. http://dx.doi.org/10.1016/j.coviro.2014.06.005.
3. Huang P, Farkas T, Marionneau S, Zhong W, Ruvoen-Clouet N, Morrow AL, Altaye M, Pickering LK, Newburg DS, LePendu J, Jiang X. 2003. Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns. J Infect Dis 188:19-31. http://dx.doi.org/10.1086/375742.
4. Huang P, Farkas T, Zhong W, Tan M, Thornton S, Morrow AL, Jiang X. 2005. Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J Virol 79:6714-6722. http://dx.doi.org/10.1128/JVI.79.11.6714-6722.2005.
5. Harrington PR, Lindesmith L, Yount B, Moe CL, Baric RS. 2002. Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice. J Virol 76:12335-12343. http://dx.doi.org/10.1128/JVI.76.23.12335-12343.2002.
6. Rockx BH, Vennema H, Hoebe CJ, Duizer E, Koopmans MP. 2005. Association of histo-blood group antigens and susceptibility to norovirus infections. J Infect Dis 191:749-754. http://dx.doi.org/10.1086/427779.
7. Tan M, Jiang X. 2005. Norovirus and its histo-blood group antigen receptors: an answer to a historical puzzle. Trends Microbiol 13:285-293. http://dx.doi.org/10.1016/j.tim.2005.04.004.
8. Tan M, Jiang X. 2011. Norovirus-host interaction: multi-selections by human histo-blood group antigens. Trends Microbiol 19:382-388. http://dx.doi.org/10.1016/j.tim.2011.05.007.
9. Cao S, Lou Z, Tan M, Chen Y, Liu Y, Zhang Z, Zhang XC, Jiang X, Li X, Rao Z. 2007. Structural basis for the recognition of blood group trisaccharides by norovirus. J Virol 81:5949-5957. http://dx.doi.org/10.1128/JVI.00219-07.
10. Bu W, Mamedova A, Tan M, Xia M, Jiang X, Hegde RS. 2008. Structural basis for the receptor binding specificity of Norwalk virus. J Virol 82: 5340-5347. http://dx.doi.org/10.1128/JVI.00135-08.
11. Kubota T, Kumagai A, Ito H, Furukawa S, Someya Y, Takeda N, Ishii K, Wakita T, Narimatsu H, Shirato H. 2012. Structural basis for the recognition of Lewis antigens by genogroup I norovirus. J Virol 86:11138-11150 http://dx.doi.org/10.1128/JVI.00278-12.
12. Shanker S, Choi JM, Sankaran B, Atmar RL, Estes MK, Prasad BV. 2011. Structural analysis of histo-blood group antigen binding specificity in a norovirus GII.4 epidemic variant: implications for epochal evolution. J Virol 85:8635-8645. http://dx.doi.org/10.1128/JVI.00848-11.
13. Jiang X, Huang P, Zhong W, Tan M, Farkas T, Morrow AL, Newburg DS, Ruiz-Palacios GM, Pickering LK. 2004. Human milk contains elements that block binding of noroviruses to human histo-blood group antigens in saliva. J Infect Dis 190:1850-1859. http://dx.doi.org/10.1086/425159.
14. Shang J, Piskarev VE, Xia M, Huang P, Jiang X, Likhosherstov LM, Novikova OS, Newburg DS, Ratner DM. 10 September 2013. Identifying human milk glycans that inhibit norovirus binding using surface plasmon resonance. Glycobiology http://dx.doi.org/10.1093/glycob/cwt077.
15. Lindesmith LC, Debbink K, Swanstrom J, Vinje J, Costantini V, Baric RS, Donaldson EF. 2012. Monoclonal antibody-based antigenic mapping of norovirus GII.4-2002. J Virol 86:873-883. http://dx.doi.org/10.1128/JVI.06200-11.
16. Koromyslova AD, Hansman GS. 2015. Nanobody binding to a conserved epitope promotes norovirus particle disassembly. J Virol 89:2718-2730. http://dx.doi.org/10.1128/JVI.03176-14.
17. Weichert S, Jennewein S, Hufner E, Weiss C, Borkowski J, Putze J, Schroten H. 2013. Bioengineered 2'-fucosyllactose and 3-fucosyllactose inhibit the adhesion of Pseudomonas aeruginosa and enteric pathogens to human intestinal and respiratory cell lines. Nutr Res 33:831-838. http://dx.doi.org/10.1016/j.nutres.2013.07.009.
18. Koromyslova AD, Leuthold MM, Bowler MW, Hansman GS. 2015. The sweet quartet: binding of fucose to the norovirus capsid. Virology 483: 203-208. http://dx.doi.org/10.1016/j.virol.2015.04.006.
19. Mallagaray A, Lockhauserbaumer J, Hansman G, Uetrecht C, Peters T. 2015. Attachment of norovirus to histo blood group antigens: a cooperative multistep process. Angew Chem Int Ed Engl 54:12014-12019. http://dx.doi.org/10.1002/anie.201505672.
20. Hansman GS, Shahzad-Ul-Hussan S, McLellan JS, Chuang GY, Georgiev I, Shimoike T, Katayama K, Bewley CA, Kwong PD. 2012. Structural basis for norovirus inhibition and fucose mimicry by citrate. J Virol 86:284-292. http://dx.doi.org/10.1128/JVI.05909-11.
21. Morrow AL, Ruiz-Palacios GM, Altaye M, Jiang X, Guerrero ML, Meinzen-Derr JK, Farkas T, Chaturvedi P, Pickering LK, Newburg DS. 2004. Human milk oligosaccharides are associated with protection against diarrhea in breast-fed infants. J Pediatr 145:297-303. http://dx.doi.org/10.1016/j.jpeds.2004.04.054.
22. Hansman GS, Biertumpfel C, Georgiev I, McLellan JS, Chen L, Zhou T, Katayama K, Kwong PD. 2011. Crystal structures of GII.10 and GII.12 norovirus protruding domains in complex with histo-blood group antigens reveal details for a potential site of vulnerability. J Virol 85:6687-6701. http://dx.doi.org/10.1128/JVI.00246-11.
23. Adams PD, Afonine PV, Bunkóczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung L-W, Kapral GJ, Grosse-Kunstleve RW, McCoy AJ, Moriarty NW, Oeffner R, Read RJ, Richardson DC, Richardson JS, Terwilliger TC, Zwart PH. 2010. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66:213-221. http://dx.doi.org/10.1107/S0907444909052925.
24. Chen VB, Arendall WB, III, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, Murray LW, Richardson JS, Richardson DC. 2010. Mol-Probity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 66:12-21. http://dx.doi.org/10.1107/S0907444909042073.
25. Morris AL, MacArthur MW, Hutchinson EG, Thornton JM. 1992. Stereochemical quality of protein structure coordinates. Proteins 12:345-364. http://dx.doi.org/10.1002/prot.340120407.
26. Singh BK, Leuthold MM, Hansman GS. 2015. Human noroviruses' fondness for histo-blood group antigens. J Virol 89:2024-2040. http://dx.doi.org/10.1128/JVI.02968-14.
27. Coulet M, Phothirath P, Allais L, Schilter B. 2014. Pre-clinical safety evaluation of the synthetic human milk, nature-identical, oligosaccharide 2'-O-fucosyllactose (2'FL). Regul Toxicol Pharmacol 68:59-69. http://dx.doi.org/10.1016/j.yrtph.2013.11.005.